Herbert Bonkovsky to Genetic Predisposition to Disease
This is a "connection" page, showing publications Herbert Bonkovsky has written about Genetic Predisposition to Disease.
Connection Strength
0.387
-
Severson TJ, Besur S, Bonkovsky HL. Genetic factors that affect nonalcoholic fatty liver disease: A systematic clinical review. World J Gastroenterol. 2016 Aug 07; 22(29):6742-56.
Score: 0.107
-
Bonacini M, Ghabril M, Bonkovsky HL. Hepatotoxicity of anti-TNF agents. Dig Dis Sci. 2014 May; 59(5):1070-1.
Score: 0.091
-
Fontana RJ, Litman HJ, Dienstag JL, Bonkovsky HL, Su G, Sterling RK, Lok AS. YKL-40 genetic polymorphisms and the risk of liver disease progression in patients with advanced fibrosis due to chronic hepatitis C. Liver Int. 2012 Apr; 32(4):665-74.
Score: 0.077
-
Sendi H, Ghaziani T, Zali MR, Adibi P, Agah M, Jazayeri M, Shahraz S, Magnius L, Bonkovsky HL. Hemochromatosis mutations in Iranians with hepatitis B virus infection. Clin Infect Dis. 2005 Feb 01; 40(3):e19-21.
Score: 0.048
-
Stolz A, Navarro V, Hayashi PH, Fontana RJ, Barnhart HX, Gu J, Chalasani NP, Vega MM, Bonkovsky HL, Seeff LB, Serrano J, Avula B, Khan IA, Cirulli ET, Kleiner DE, Hoofnagle JH. Severe and protracted cholestasis in 44 young men taking bodybuilding supplements: assessment of genetic, clinical and chemical risk factors. Aliment Pharmacol Ther. 2019 05; 49(9):1195-1204.
Score: 0.032
-
Bonkovsky HL, Obando JV. Role of HFE gene mutations in liver diseases other than hereditary hemochromatosis. Curr Gastroenterol Rep. 1999 Feb-Mar; 1(1):30-7.
Score: 0.032